Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01702194
PHASE1

TD-1211 IV/Oral Mass Balance Study

Sponsor: Glycyx Therapeutics

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine TD-1211 is processed by the body.

Official title: A Single-Dose, Fixed-Sequence, Two-Period, Two-Treatment Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-1211 Following an Intravenous Infusion and an Oral Dose of [14C]TD-1211 in Healthy Male Subjects

Key Details

Gender

MALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2012-11

Completion Date

2013-03

Last Updated

2026-05-22

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

TD-1211 IV [C14]

DRUG

TD-1211 PO [C14]

Locations (1)

Covance

Madison, Wisconsin, United States